Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00377949 · ClinicalTrials.gov registry record
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
A clinical trial, sponsored by Georgetown University.
- Completed
- Registry status
- 602
- Enrollment target
NCT00377949 is a clinical trial that has completed, run by Georgetown University. The registered enrollment target is 602 participants.
The verdict
NCT00377949 has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- 602 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the timeline of progression from pre-pulmonary hypertension to diagnosable pulmonary hypertension based on right heart catheterization. Moreover, to determine the timeline for progression from diagnosable pulmonary hypertension to clinical worsening of disease as defined as death, hospitalization, or worsening of PHT symptoms.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 602 participants |
| Start Date | 2005-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00377949
The ClinicalTrials.gov registry entry for NCT00377949 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 602 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00377949 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00377949 about?
NCT00377949 is a clinical study titled "Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients". The purpose of this study is to determine the timeline of progression from pre-pulmonary hypertension to diagnosable pulmonary hypertension based on right heart catheterization. Moreover, to determine the timeline for progression from diagnosable pulmonary hypertension to clinical worsening of disea...
What is the current status of trial NCT00377949?
This trial is currently completed. The enrollment target is 602 participants. The study started on 2005-02.
Who is sponsoring clinical trial NCT00377949?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.